Canada markets open in 2 hours 56 minutes

Kane Biotech Inc. (KNE.V)

TSXV - TSXV Real Time Price. Currency in CAD
Add to watchlist
0.0900-0.0100 (-10.00%)
At close: 02:42PM EDT
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2021-12-31
2020-12-31
2019-12-31
2018-12-31
Total Revenue
1,608
1,608
1,342
1,694
506.273
Cost of Revenue
1,039
1,039
814.715
1,084
390.802
Gross Profit
568.441
568.441
526.859
609.912
115.471
Operating Expenses
Research Development
1,377
1,377
1,326
1,541
922.526
Selling General and Administrative
4,075
4,075
3,425
2,659
2,372
Total Operating Expenses
5,452
5,452
4,751
4,200
3,294
Operating Income or Loss
-4,884
-4,884
-4,224
-3,590
-3,179
Interest Expense
416.057
416.057
121.556
141.675
89.777
Total Other Income/Expenses Net
327.773
327.773
461.653
2,771
-2.01
Income Before Tax
-4,850
-4,850
-3,846
-960.178
-3,261
Income from Continuing Operations
-4,850
-4,850
-3,846
-960.178
-3,261
Net Income
-4,605
-4,605
-3,717
-960.178
-3,261
Net Income available to common shareholders
-4,605
-4,605
-3,717
-960.178
-3,261
Basic EPS
-
-
-0.03
-0.01
-0.04
Diluted EPS
-
-
-0.03
-0.01
-0.04
Basic Average Shares
-
-
107,549
101,532
80,114
Diluted Average Shares
-
-
107,549
101,532
80,114
EBITDA
-
-4,246
-3,646
-764.079
-3,099